Adaptive Biotechnologies vs Kanso Diagnostics
Adaptive Biotechnologies vs Kanso Diagnostics, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Kanso Diagnostics on 53/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 53/100
- agent readiness: 39/100 against 28/100
- domain rating: 61/100 against 1/100
- funding raised: $300M against $1.8M
Kanso Diagnostics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Adaptive Biotechnologies | Kanso Diagnostics |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Healthcare, Diagnostics, Genetics, Pathology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Platform |
| Founded | 2009 | 2021 |
| Headquarters | Seattle, United States | Or Yehuda, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Kanso Diagnostics |
|---|---|---|
| Employees | Not published | 7 |
| Headcount growthLast 12 months | Not published | +22.1% |
| Total funding | $300M | $1.8M |
| Latest round | Series D | Seed |
| LinkedIn followers | Not published | 778 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Kanso Diagnostics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 53/100 |
| Traction | Not published | 40/100 |
| Team | Not published | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | Not published | 39/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (28/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 1/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Kanso Diagnostics |
|---|---|---|
| Hosting | Self Managed | Netlify |
| CDN | Not detected | Netlify |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
Adaptive Biotechnologies vs Kanso Diagnostics: common questions
Which is better, Adaptive Biotechnologies or Kanso Diagnostics?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Kanso Diagnostics compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 53/100), agent readiness (39/100 against 28/100), domain rating (61/100 against 1/100), funding raised ($300M against $1.8M).
Read the full Adaptive Biotechnologies review and pricing or the Kanso Diagnostics review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.